Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma

被引：0
作者：
Sachie Kiryu
Zensho Ito
Machi Suka
Tsuuse Bito
Shin Kan
Kan Uchiyama
Masayuki Saruta
Taigo Hata
Yuki Takano
Shuichi Fujioka
Takeyuki Misawa
Takashi Yamauchi
Hiroyuki Yanagisawa
Nobuhiro Sato
Toshifumi Ohkusa
Haruo Sugiyama
Shigeo Koido
机构：
[1] The Jikei University School of Medicine,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[2] Kashiwa Hospital,Department of Public Health and Environmental Medicine
[3] The Jikei University School of Medicine,Institute of Clinical Medicine and Research
[4] The Jikei University School of Medicine,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[5] The Jikei University School of Medicine,Department of Surgery
[6] The Jikei University School of Medicine,Department of Microbiota Research
[7] Kashiwa Hospital,Department of Functional Diagnostic Science
[8] Juntendo University Graduate School of Medicine,undefined
[9] Osaka University Graduate School of Medicine,undefined
来源：
BMC Cancer | / 21卷
关键词：
Foxp3; Immune-related cells; Pancreatic cancer; Prognosis; PD-1; TIL; Surgical resection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 197 条
[1]  
Knudsen ES(2017)Stratification of pancreatic ductal adenocarcinoma: combinatorial genetic, stromal, and immunologic markers Clin Cancer Res Off J Am Assoc Cancer Res 23 4429-4440
[2]  
Vail P(2011)Current immunotherapeutic approaches in pancreatic cancer Clin Dev Immunol 2011 267539-9365
[3]  
Balaji U(2020)The role of genetic polymorphism within PD-L1 gene in cancer. Review Exp Mol Pathol 116 104494-452
[4]  
Ngo H(2017)Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer Oncotarget 8 9354-1639
[5]  
Botros IW(2018)Regulation and function of the PD-L1 checkpoint Immunity 48 434-32
[6]  
Makarov V(2018)Immune cell and stromal signature associated with progression-free survival of patients with resected pancreatic ductal adenocarcinoma Gastroenterology 155 1625-439
[7]  
Koido S(2001)Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol Rev 182 18-5434
[8]  
Homma S(2020)Regulatory T-cell Depletion Alters the Tumor Microenvironment and accelerates pancreatic carcinogenesis Cancer Discov 10 422-185
[9]  
Takahara A(2006)Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions Clin Cancer Res Off J Am Assoc Cancer Res 12 5423-8350
[10]  
Namiki Y(2020)FoxP3(+) T regulatory cells in cancer: prognostic biomarkers and therapeutic targets Cancer Lett 490 174-99
12345678910